PRE-CONFERENCE – PRELIMINARY PROGRAMME

Within the two weeks preceding the event, three-day training courses will be taking place (on-line) on different days, more information to be published soon. 

UTC-GMT

Pre-meeting Training | 2021 Annual ISoP Meeting

07.00 – 14.30

Pre – conference course 1
Pharmaco-epidemiological methods in pharmacovigilance

Pre – conference course 2
Managing safety signals: License Holder and Health Authority perspectives

Pre – conference course 3
Making and Assessing Periodic Benefit-Risk Evaluation Reports (PSUR/PBRERs)

(in collaboration with the WHO) 

 

ISoP 2021 – PRELIMINARY PROGRAMME

Monday 8 November

 

Session

 

 

Timing

 

Time 

UTC-GMT

 

Session title

1A

20′

07.00– 07.20

Opening ceremony
Mira Harrison-Woolrych (President of ISoP), Sten Olsson (Chair of the Scientific Committee), and Mayada Alkhakany (Chair of the Local Organising Committee)

1A

70′

07.20 -08.30

Session:
Global post marketing safety surveillance of Covid-19 vaccines – planning and implementation (Part I)
Session chairpersons: Sten Olsson (ISoP) & Shanthi Pal (WHO)

30′

08.30 – 9.00

Break and poster viewing

1B

90′

09.00-10.30

Session on Covid-19 vaccine safety surveillance (Part II)
Session chairpersons: Sten Olsson (ISoP) & Shanthi Pal (WHO)

30′

10.30 – 11.00

Break and poster viewing 

1C

90′

11.00 – 12.30

Session: Coordinating key stakeholders of national pharmacovigilance systems
Session chairpersons: Manal Younus (Iraqi Pharmacovigilance Center, Ministry of Health, Iraq)
& Jean-Christophe Delumeau (Bayer, Singapore)                            

30′

12.30 -13.00

Break and poster viewing

1D

90′

13.00 – 14.30

Session: Harmonizing safety surveillance across different groups of health products (Part I)
Session chairpersons: Comfort Ogar (Management Sciences for Health, Nigeria) & Thamer Alshammary
(King Saud University, Saudi Arabia)

30′

14.30 – 15.00

Break and poster viewing

1E

90′

15.00 – 16.30

Session: Harmonizing safety surveillance across different groups of health products (Part II)
Session chairpersons: Comfort Ogar (Management Sciences for Health, Nigeria) & Thamer Alshammary (King Saud University, Saudi Arabia)

30′

16.30 -17.00

Break and poster viewing

1F

90′

17.00 -18.30

Session: Integrating safety data and knowledge from different information sources
Session chairperson: Andrew Bate (GSK, UK)

 

Tuesday 9 November

Session

Timing

Time 

UTC-GMT

Session title

2A

90′

07.00- 08.30

Session: Risks and benefits of medicines in pregnancy: how can pharmacovigilance support women and their families?                                              
Session chairpersons: Mira Harrison-Woolrych (President of ISoP) & Manal Younus (Iraqi Pharmacovigilance Center, Ministry of Health, Iraq)
(In collaboration with ISoP Women’s Medicines SIG)

 

 

08.30-09.00

Break and poster viewing

2B

90′

09.00-10.30

Session: Incorporating new patient safety challenges into pharmacovigilance
 
Session chairpersons: Thamer Alshammari (King Saud University, Saudi Arabia) & Andrea Kuemmerle (Switzerland)

30′

10.30-11.00

Break and poster viewing

2C

90′

11.00-12.30

Session: Trends in development of global regulatory frameworks for pharmacovigilance
 
Session chairperson: Sten Olsson (ISoP)

30′

12.30 – 13.00

Break and poster viewing

2D

30′

13.00 -14.00

ISoP General Assembly

2D

30′

14.00 -14.30

Plenary lecture – Beje Lecture
 Session chairperson: Shanthi Pal (WHO)

A unified national approach for safety surveillance of all medicinal products – a case study

30′

14.30 -15.00

Break and poster viewing

2E

90′

15.00-16.30

Session: Promoting Patient Safety through Pharmacovigilance Infographics
 
Session chairpersons: Angela Caro (Colombian Pharmacovigilance Association, Colombia) & Priya Bahri (European Medicines Agency, Netherlands)

30′

16.30 – 17.00

Break and poster viewing

2F

30′

17.00-18.30

Session: Global pharmacovigilance: Hot topics from the ISoP regions
 
Session chairperson: Rebecca Chandler (Uppsala Monitoring Centre)

Wednesday 10 November

 

Session

 

 

Timing

 

Time

UTC-GMT

 

Session Title

3A

90′

07.00-08.30

Session: Combining local, regional and global perspectives in pharmacovigilance – increasing reliance
 
Session chairpersons: Jean-Christophe Delumeau (Bayer, Singapore), Manal Younus (Iraqi Pharmacovigilance Center, Ministry of Health, Iraq) & Comfort Ogar (Management Sciences for Health, Nigeria)

30′

08.30-09.00

Break and poster viewing 

3B

90′

09.00-10.30

Session: Integrating pharmacovigilance monitoring of vaccines into national and international public health
 
Session chairpersons: Rebecca Chandler (Uppsala Monitoring Centre) & Andrea Kuemmerle (Switzerland)

30′

10.30.11.00

Break and poster viewing

3C

30′

11.00-11.30

CIOMS lecture: Patient involvement in the development and safe use of medicines
 

3D

30′

11.30 -12.00

Keynote lecture 
 

15′

12.00 – 12.45

Poster prize awards

45′

12.00 – 12.45

Poster prize awards and short communication from winners

15′

12.45 – 13.00

ISoP 2022 statement and Closing remarks

ISOP 2021 Secretariat: C-IN, 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301
Copyright © 2020 c-in.eu | info@isop2021oman.org